News | May 27, 2022
DFE Pharma opens its new Center of Excellence in Hyderabad, India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
India has the second-largest number of adults with diabetes globally, after China
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
Building the future of food in the birthplace of cell-cultured milk
Subscribe To Our Newsletter & Stay Updated
